Hexa-acylated lipopolysaccharides from the gut microbiota enhance cancer immunotherapy responses
B. S. Beresford-Jones, P. Sardar, W. Xia, O. Shabana, S. Suyama, R. J. J. F. Ramos, A. T. Soderholm, P. Tourlomousis, P. Kuo, A. C. Evans, C. J. Imianowski, A. G. Conti, A. J. Wesolowski, K. Okkenhaug, S. K. Whiteside, , V. A. Pedicord
The paper identifies hexa-acylated lipopolysaccharides from the gut microbiome as a biomarker and enhancer of anti-PD-1 immunotherapy responses in melanoma patients.
bioRxiv · Jun 24, 2024Microbiology